Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis.
OBJECTIVE
We explored whether the distribution of adipose cell size, the estimated total number of adipose cells, and the expression of adipogenic genes in subcutaneous adipose tissue are linked to the phenotype of high visceral and low subcutaneous fat depots in obese adolescents.


METHODS
A total of 38 adolescents with similar degrees of obesity agreed to have a subcutaneous periumbilical adipose tissue biopsy, in addition to metabolic (oral glucose tolerance test and hyperinsulinemic euglycemic clamp) and imaging studies (MRI, DEXA, (1)H-NMR). Subcutaneous periumbilical adipose cell-size distribution and the estimated total number of subcutaneous adipose cells were obtained from tissue biopsy samples fixed in osmium tetroxide and analyzed by Beckman Coulter Multisizer. The adipogenic capacity was measured by Affymetrix GeneChip and quantitative RT-PCR.


RESULTS
Subjects were divided into two groups: high versus low ratio of visceral to visceral + subcutaneous fat (VAT/[VAT+SAT]). The cell-size distribution curves were significantly different between the high and low VAT/(VAT+SAT) groups, even after adjusting for age, sex, and ethnicity (MANOVA P = 0.035). Surprisingly, the fraction of large adipocytes was significantly lower (P < 0.01) in the group with high VAT/(VAT+SAT), along with the estimated total number of large adipose cells (P < 0.05), while the mean diameter was increased (P < 0.01). From the microarray analyses emerged a lower expression of lipogenesis/adipogenesis markers (sterol regulatory element binding protein-1, acetyl-CoA carboxylase, fatty acid synthase) in the group with high VAT/(VAT+SAT), which was confirmed by RT-PCR.


CONCLUSIONS
A reduced lipo-/adipogenic capacity, fraction, and estimated number of large subcutaneous adipocytes may contribute to the abnormal distribution of abdominal fat and hepatic steatosis, as well as to insulin resistance in obese adolescents.
Kursawe
Romy
R
Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Eszlinger
Markus
M
Narayan
Deepak
D
Liu
Teresa
T
Bazuine
Merlijn
M
Cali
Anna M G
AM
D'Adamo
Ebe
E
Shaw
Melissa
M
Pierpont
Bridget
B
Shulman
Gerald I
GI
Cushman
Samuel W
SW
Sherman
Arthur
A
Caprio
Sonia
S
D050153:Abdominal Fat / Q000473:pathology / Q000503:physiopathology; D000293:Adolescent; D001706:Biopsy; D049628:Body Size; D003971:Diastole; D005234:Fatty Liver / Q000473:pathology* / Q000503:physiopathology; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance / Q000502:physiology*; D050152:Intra-Abdominal Fat / Q000033:anatomy & histology* / Q000473:pathology*; D008055:Lipids / Q000502:physiology; D008297:Male; D018482:Muscle, Skeletal / Q000473:pathology / Q000503:physiopathology; D009765:Obesity / Q000473:pathology*; D044469:Racial Groups; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D050507:Subcutaneous Fat, Abdominal / Q000033:anatomy & histology* / Q000473:pathology*; D013599:Systole; D049629:Waist-Hip Ratio
D007328:Insulin; D008055:Lipids
PLoS One. 2007 Jun 27;2(6):e569
17593968
J Clin Endocrinol Metab. 2006 Nov;91(11):4287-94
16912127
Hypertension. 2005 May;45(5):828-33
15824195
J Biol Chem. 2004 Jul 9;279(28):29558-64
15123608
Diabetes. 2006 Oct;55(10):2811-8
17003347
J Intern Med. 2007 Jul;262(1):131-9
17598821
J Biol Chem. 1987 Jun 25;262(18):8463-6
3597382
Diabetes Care. 2004 Jul;27(7):1660-7
15220243
Biochem J. 2008 Dec 1;416(2):e11-3
18990086
J Clin Invest. 2000 Feb;105(3):271-8
10675352
Nat Genet. 2001 Jan;27(1):121-4
11138012
Lancet. 2003 Sep 20;362(9388):951-7
14511928
Cell Metab. 2008 May;7(5):410-20
18460332
Biostatistics. 2003 Apr;4(2):249-64
12925520
Ann N Y Acad Sci. 2002 Jun;967:363-78
12079864
Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E988-93
12376326
J Clin Endocrinol Metab. 2005 Feb;90(2):1163-70
15522933
Hepatology. 2009 Jun;49(6):1896-903
19434725
Diabetologia. 2009 May;52(5):882-90
19252892
Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E435-42
17440034
Biochem Biophys Res Commun. 2004 May 14;317(4):1045-51
15094374
J Clin Invest. 2000 Jul;106(2):171-6
10903330
Obes Res. 2000 Mar;8(2):171-8
10757203
Magn Reson Med. 2008 Mar;59(3):521-7
18306404
Diabetologia. 2000 Dec;43(12):1498-506
11151758
Nat Genet. 2000 Sep;26(1):13
10973236
Int J Obes (Lond). 2006 Jun;30(6):899-905
16446749
Am J Physiol. 1979 Sep;237(3):E214-23
382871
Nat Genet. 2003 Jul;34(3):267-73
12808457
Diabetes Care. 1999 Sep;22(9):1462-70
10480510
Lipids. 1981 Nov;16(11):830-4
7311742
Nature. 2008 Jun 5;453(7196):783-7
18454136
J Lipid Res. 2006 Nov;47(11):2444-50
16894240
Cell Metab. 2005 Jan;1(1):73-83
16054046
Genes Dev. 1996 May 1;10(9):1096-107
8654925
Diabetes. 2008 Feb;57(2):367-71
17977954
PLoS One. 2010 Jan 22;5(1):e8197
20107501
PLoS Comput Biol. 2009 Mar;5(3):e1000324
19325873
Int J Obes Relat Metab Disord. 2003 Oct;27(10):1178-86
14513065
Obes Res. 2004 Jun;12(6):990-8
15229339
BMC Bioinformatics. 2008 Sep 25;9:399
18817533
J Clin Endocrinol Metab. 2008 May;93(5):1767-73
18303080
Diabetologia. 2007 Aug;50(8):1707-15
17549449
J Clin Invest. 1989 Jul;84(1):305-11
2738155